McLean Hospital 115 Mill Street Belmont, MA 02478
Rakesh Karmacharya, MD, PhD, is applying chemical biology approaches to identify disease signatures for schizophrenia and bipolar disorder, using neuronal cells generated from patient-derived induced pluripotent stem cells (iPSCs). The goal is to find reliable and robust cellular features that segregate with disease then can serve as disease signatures. The identification of disease signatures will enable screens of small molecule libraries to delineate molecular targets that modulate these disease signatures and identify new diagnostic and therapeutic leads for schizophrenia and bipolar disorder.
Dr. Karmacharya is co-medical director of McLean OnTrackTM and an assistant professor of psychiatry at Harvard Medical School. Author of numerous journal articles, he is on the editorial board of Journal of Stem Cell Research & Regenerative Medicine and Archives of Stem Cell Research.
Belmont campus - Admissions Building, Room G-S093